Apis Capital Advisors LLC Increases Holdings in Viemed Healthcare, Inc. (NASDAQ:VMD)

Apis Capital Advisors LLC raised its stake in Viemed Healthcare, Inc. (NASDAQ:VMD - Free Report) by 14.4% in the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 279,600 shares of the company's stock after buying an additional 35,200 shares during the quarter. Viemed Healthcare makes up approximately 1.5% of Apis Capital Advisors LLC's investment portfolio, making the stock its 18th largest position. Apis Capital Advisors LLC owned about 0.72% of Viemed Healthcare worth $2,242,000 as of its most recent filing with the Securities & Exchange Commission.

Other hedge funds and other institutional investors have also modified their holdings of the company. R Squared Ltd purchased a new position in shares of Viemed Healthcare during the 4th quarter worth approximately $41,000. EntryPoint Capital LLC acquired a new stake in shares of Viemed Healthcare in the fourth quarter valued at $92,000. Prudential Financial Inc. acquired a new position in Viemed Healthcare during the 4th quarter worth about $93,000. Oxford Asset Management LLP acquired a new position in Viemed Healthcare in the 4th quarter valued at about $98,000. Finally, Price T Rowe Associates Inc. MD lifted its position in shares of Viemed Healthcare by 18.1% during the fourth quarter. Price T Rowe Associates Inc. MD now owns 13,005 shares of the company's stock worth $105,000 after purchasing an additional 1,997 shares in the last quarter. 74.24% of the stock is owned by institutional investors and hedge funds.

Viemed Healthcare Stock Down 9.6 %

VMD traded down $0.70 during trading hours on Thursday, hitting $6.57. 234,058 shares of the company's stock were exchanged, compared to its average volume of 140,421. The firm has a 50 day moving average of $7.12 and a 200 day moving average of $7.96. The firm has a market cap of $259.67 million, a P/E ratio of 24.33 and a beta of 1.49. The company has a current ratio of 1.31, a quick ratio of 1.19 and a debt-to-equity ratio of 0.03. Viemed Healthcare, Inc. has a 12-month low of $6.21 and a 12-month high of $9.81.

Viemed Healthcare (NASDAQ:VMD - Get Free Report) last released its earnings results on Wednesday, May 7th. The company reported $0.06 earnings per share (EPS) for the quarter, meeting analysts' consensus estimates of $0.06. The firm had revenue of $59.10 million during the quarter, compared to analyst estimates of $60.60 million. Viemed Healthcare had a return on equity of 8.72% and a net margin of 4.87%.

Viemed Healthcare Profile

Viemed Healthcare, Inc, together with its subsidiaries, provides home medical equipment (HME) and post-acute respiratory healthcare services to patients in the United States. It provides respiratory disease management solutions, including treatment of chronic obstructive pulmonary disease (COPD), which include non-invasive ventilation, percussion vests, and other therapies; and invasive and non-invasive ventilation and related equipment and supplies to patients suffering from COPD.